RecallDepth
Class III Terminated

Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle (NDC 43975-252-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ 07071

Company
Amerigen Pharmaceuticals Inc.
Recall Initiated
February 19, 2019
Posted
February 27, 2019
Recall Number
D-0516-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 2,413 bottles b) 3,355 bottles
Firm Location
Lyndhurst, NJ, United States

Reason for Recall

Failed dissolution specifications

Distribution

Product was distributed to 4 wholesalers/distributors and 1 retail account who may have further distribute the product throughout the United States.

Lot / Code Info

Lot #: a) 18J043A, Exp 09/30/2020, b) 18J043B, Exp 09/30/2020

More recalls by Amerigen Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class III Drug recalls